A simple test of in vitro thyroxine binding to serum proteins was used to screen serum samples from euthyroid patients with unexplained increases in the free thyroxine index. A diagnosis of familial dysalbuminaemic hyperthyroxinaemia was presumed in 14 unrelated subjects and six first degree relatives. Increased binding of thyroxine to thyroxine binding prealbumin was diagnosed in one woman with four unaffected relatives. Seven patients with familial dysalbuminaemic hyperthyroxinaemia had been treated for presumed thyrotoxicosis: two had typical Graves' disease and one subacute thyroiditis. Four other patients had been mistakenly treated with radioactive iodine or antithyroid drugs. In previously treated patients familial dysalbuminaemic hyperthyroxinaemia was suspected from the combination of a high serum thyroid stimulating hormone concentration and a normal but invalid free thyroxine index.
Introduction
A raised serum total thyroxine concentration or free thyroxine index may be mistaken for thyrotoxicosis in the syndrome of familial dysalbuminaemic hyperthyroxinaemia,l-3 an autosomal dominant syndrome resulting from unusual, high capacity binding of thyroxine to serum albumin. In this syndrome serum free thyroxine concentrations tested by equilibrium dialysis, serum triiodothyronine concentration, and thyrotrophin releasing hormone responses are normal and affected subjects are usually euthyroid.
Subjects with this protein binding variant may also present with an apparently normal free thyroxine index in the presence of hypothyroidism induced by radioactive iodine or treatment with antithyroid drugs. In this report we describe the diagnostic usefulness of a simple in vitro test of serum thyroxine binding.
Patients and methods
We studied 42 patients (eight men and 34 women), aged 17-72 years, referred to the thyroid clinic for assessment of possible thyrotoxicosis diagnosed on the basis of a raised free thyroxine index. Serum samples from 32 of these patients were further analysed because of the combination of a raised serum free thyroxine index and a normal thyrotrophin releasing hormone response. In the 10 other patients a change in the normal relation between basal serum thyroid stimulating hormone concentration and free thyroxine index had been observed. Seven of the 42 patients had been treated for thyrotoxicosis.
We measured the basal serum free thyroxine index, free triiodothyronine index, thyroid stimulating hormone concentrations, and the response of thyroid stimulating hormone to stimulation with thyrotrophin releasing hormone, as previously defined and reported.5
Basal thyroid stimulating hormone concentrations were also measured by radioimmunoassay modified to increase sensitivity to 01 UU/ml; results from this assay correlated well with the increment in thyroid stimulating hormone after thyrotrophin releasing hormone stimulation (r=0 92) and similarly distinguished normal subjects from patients with subnormal thyroid stimulating hormone concentrations and definite thyrotoxicosis.6 In 11 subjects with familial dysalbuminaemic hyperthyroxinaemia the serum free thyroxine concentration was also estimated directly by both Amerlex (Amersham) and Gammacoat two step (Clinical Assays) kit methods.
SERUM THYROXINE BINDING TESTS
The binding of thyroxine labelled with iodine-125 (1251) to serum proteins was estimated by a modified version of our in house triiodothyronine resin uptake method using heat denatured macroaggregated albumin as the adsorbent. Bovine serum albumin (0 25%) in acetate buffer (0-3M, pH was denatured by heating at 80°C for one hour. The particles of macroaggregated albumin were separated by centrifugation, resuspended in 50 ml trometamol (TRIS) saline buffer (0-05M, pH 7 5) , and then aspirated through a 20 g needle to produce particles of a uniform size (approximately 10 4em in diameter). Working reagent was prepared by diluting the solution of macroaggregated albumin with 500 ml trometamol saline buffer, adding cold thyroxine to a concentration of 1 3nM and 125I labelled thyroxine (high specific activity, Amersham) to 40 000 cpm.
To perform the assay 10 tel serum was incubated with 1 ml of this working reagent for 10 minutes at room temperature, centrifuged, and decanted and the 125I labelled thyroxine uptake of the macroaggregated albumin was counted. The reagent volume was adjusted with buffer such that normal serum gave an uptake of roughly 200' of the added counts. The uptake of thyroxine loaded macroaggregated albumin was obtained by repeating the test as described above in the presence of a 50-fold excess of cold thyroxine by adding 10 /A of cold thyroxine standard (5,uM) to the 10 z1l serum sample. For a one to 100 dilution of serum (thyroxine concentration about 10-9M) this gives a final thyroxine concentration of 5 x 10 -8M in the incubation mixture. 4 In screening for the presence of possible excess thyroxine binding to prealbumin a 1000-fold excess of added cold thyroxine was used to give a final thyroxine concentration of 10-6M. 7 The results were calculated and expressed as the increment between the percentage basal and thyroxine loaded macroaggregated albumin uptakes of "5I labelled thyroxine. The unpaired Student's t test was used in statistical analysis (table I) .
Results
We found anomalous thyroxine binding in the serum of 14 unrelated subjects and six members of four families tested. These patients had been selected for study because of conflicting clinical and laboratory results. The results of the in vitro thyroxine binding tests in these subjects indicated that dysalbuminaemia was the likely cause of the raised free thyroxine index. The free thyroxine index was raised in all 14 untreated subjects (mean 192 (normal 70-145), range 155-337). All 14 appeared to be clinically euthyroid and had a normal free triidothyronine index. Thyrotrophin releasing hormone stimula-BRITISH MEDICAL JOURNAL VOLUME 290 13 APRIL 1985 500i\ *.\ Conversion: SI to traditional units-Thyroxine: 1 pmol/l 78 pg/100 ml. 4 Using their method we detected dysalbuminaemic hyperthyroxinaemia in the serum of 14 unrelated subjects and six members of four families tested.
We had incorrectly diagnosed thyrotoxicosis in four patients because of our overreliance on a raised free thyroxine index combined with possible symptoms of thyrotoxicosis, particularly anxiety. In two of these patients the development of a goitre and a raised isotopic neck uptake during antithyroid drug treatment were additional diagnostic distractors. Newer methods for oj measuring free thyroxine also gave misleading results, as previously described." Free thyroxine concentrations measured by equilibrium dialysis, serum triiodothyronine concentrations measured by radioimmunoassay, and results of thyrotrophin releasing hormone stimulation tests are all normal in this syndrome. ' Other possible causes of euthyroid hyperthyroxinaemia in this group of patients include non-thyroidal illness and the use of drugs that interfere with thyroxine metabolism, such as amiodarone or propranolol.9 These causes were easily excluded both by the history and our failure to detect abnormal thyroxine binding in serum from such patients. The combination of familial dysalbuminaemic hyperthyroxinaemia with thyrotoxicosis delayed complete diagnosis in two patients until we appreciated the importance of an unusually high free thyroxine index after induced hypothyroidism. The anomalous binding of albumin and thyroxine increases the normal total serum thyroxine concentration by about 100 nmol/l (7 8 tg/100 ml).10 In the present study we observed a comparable increase of 80 nmol/l (6 2 ,ug/100 ml) in 11 untreated subjects. The shift to the right in the usual inverse relation between thyroid stimulating hormone and free thyroxine index also reflects the increase in serum thyroxine binding (fig 1) . Since introducing a modified sensitive serum thyroid stimulating hormone assay to screen for the presence of thyrotoxicosis we have diagnosed two additional patients with familial dysalbuminaemic hyperthyroxinaemia in this way.
Only two reports have previously described hyperthyroxin- Our report emphasises the need for physicians to be cautious in accepting a diagnosis of thyrotoxicosis based primarily on a raised serum thyroxine concentration obtained in a screening test. Classic features of goitre, exophthalmos, positive serum thyroid antimicrosomal antibodies, and a raised isotopic neck uptake are usually absent in familial dysalbuminaemic hyperthyroxinaemia and will lend support to the presence of true thyrotoxic Graves' disease. A raised serum triiodothyronine concentration seen by radioimmunoassay, an absent thyrotrophin releasing hormone response, or a subnormal serum thyroid stimulating hormone concentration will further exclude familial dysalbuminaemic hyperthyroxinaemia as the sole diagnosis.
The incidence of familial dysalbuminaemic hyperthyroxinaemia due to abnormal albumin binding remains unknown. We diagnosed these anomalies in thyroxine binding over 18 months in subjects drawn from a population of about one million. Our results suggest that the wider use of in vitro thyroxine binding tests will show many further examples of these recently described protein variants.
